Related Experiment Video
Updated: Jun 6, 2026
09:52
Non-invasive Optical Imaging of the Lymphatic Vasculature of a Mouse
Published on: March 8, 2013
PET imaging in lymphoma.
1Departments of Oncology and Haematology, Rigshospitalet, The Finsen Centre-Copenhagen University Hospital, 9 Blegdamsvej, Copenhagen Ø, Denmark. hutchings@dadlnet.dk
Expert Review of Hematology
|November 19, 2010
Summary
Positron Emission Tomography (PET) is crucial for managing lymphoma. This review covers current PET applications, clinical trials, and future developments in lymphoma treatment.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiology
Background:
- Positron Emission Tomography (PET) is integral to contemporary lymphoma care.
- Clinical decisions in lymphoma management are increasingly guided by PET imaging.
Purpose of the Study:
- To review the clinical evidence for PET utilization across various lymphoma subtypes.
- To examine the role of PET in different stages of lymphoma treatment.
- To provide an overview of current PET-based interventional trials and future directions.
Main Methods:
- Literature review of clinical studies and trials involving PET in lymphoma.
- Analysis of evidence supporting PET's efficacy in lymphoma management.
- Exploration of ongoing and future PET-based research in lymphoma.
Main Results:
- PET is a cornerstone in lymphoma management, influencing treatment strategies.
- Evidence supports PET's use in diagnosing, staging, and monitoring treatment response.
- Current trials are exploring PET-guided interventions, with new tracers on the horizon.
Conclusions:
- PET imaging is indispensable for effective lymphoma management.
- Future research will likely focus on novel PET tracers and advanced imaging techniques.
- PET-guided therapy holds promise for personalized lymphoma treatment.
